|
Volumn 11, Issue , 1999, Pages 104-117
|
Future developments of antipsoriatic therapy
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AE 941;
ANGIOGENESIS INHIBITOR;
ASCOMYCIN;
CYTOKINE;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HYBRID PROTEIN;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 10;
LEFLUNOMIDE;
LEUKOTRIENE B4 RECEPTOR ANTAGONIST;
LIAROZOLE;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NEUROPEPTIDE;
NITRIC OXIDE SYNTHASE INHIBITOR;
OKT 4;
OMEGA 3 FATTY ACID;
PELDESINE;
PROPYLTHIOURACIL;
RAPAMYCIN;
SDZ 281240;
SDZ ASA 981;
SYNTHETIC PEPTIDE;
T LYMPHOCYTE RECEPTOR;
TACROLIMUS;
THIAMAZOLE;
TROGLITAZONE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
UROCANIC ACID;
ANGIOGENESIS;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TOLERABILITY;
GENE THERAPY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
PHOTODYNAMIC THERAPY;
PSORIASIS;
REVIEW;
|
EID: 0032866006
PISSN: 13960296
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (7)
|
References (131)
|